実験動物モデル、3D培養、オルガノイドの世界市場

世界のオルガノイドの市場規模は、2022年に14億米ドルになるとみられています。

同市場は、2022年～2027年の予測期間中に22.2％のCAGRで拡大し、2027年には37億米ドルに達すると予測されています。

当レポートでは、世界のオルガノイド市場について調査し、市場の概要とともに、臓器タイプ別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 まとめとハイライト

第3章 動物モデル市場の技術背景

第4章 世界のオルガノイド市場に対するCOVID-19の影響

第5章 市場力学

第6章 3D細胞技術の背景

第7章 市場内訳、臓器タイプ別

• 世界のオルガノイド市場、臓器タイプ別
• 腸
• 肝臓
• 胃
• 膵臓
• 肺
• 肝臓
• その他

第8章 市場内訳、用途別

• 世界のオルガノイド市場、用途別
• 発生生物学
• 創薬と個別化医療
• 再生医療
• 感染症の病理学
• 薬物毒性および有効性試験

第9章 市場内訳、地域別

• 世界のオルガノイド市場、地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第10章 特許レビュー/新展開

第11章 市場機会の分析

第12章 競合情勢

第13章 企業および重要機関の概要

• 動物モデル企業
• ALPHA GENESIS INC.
• CHARLES RIVER LABORATORIES INTERNATIONAL INC.
• ENVIGO
• GENOWAY S.A.
• LABCORP DRUG DEVELOPMENT (COVANCE INC.)
• THE JACKSON LABORATORY
• JANVIER LABS
• OAK HILL GENETICS
• PRIMGEN
• TACONIC BIOSCIENCES
• TRANSGENIC INC.
• TRANSPOSAGEN BIOPHARMACEUTICALS INC.
• バイオプリント・再生医療企業
• ALLEVI
• ASPECT BIOSYSTEMS LTD.
• BIOINK SOLUTIONS INC.
• CELLINK INC.
• COLLPLANT HOLDINGS LTD.
• EAST RIVER BIOSOLUTIONS/XYLYX BIO
• EPIBONE
• MATTEK CORP.
• NANO 3D BIOSCIENCES INC.
• ORGANOVO HOLDINGS INC.
• PEPGEL LLC
• REGENHU
• TEVIDO BIODEVICES INC.
• TISSUSE GMBH
• オーガン・オン・チップ企業
• AXOSIM
• EMULATE INC.
• KIRKSTALL LTD.
• MICRONIT MICROTECHNOLOGIES
• MIMETAS
• TARA BIOSYSTEMS INC.
• オルガノイド企業
• 3DNAMICS INC.
• CELLESCE
• CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
• CROWN BIOSCIENCE
• CORNING INC.
• DEFINIGEN
• HUBRECHT ORGANOID TECHNOLOGY (HUB)
• MERCK KGAA
• R&D SYSTEMS INC.
• STEMCELL TECHNOLOGIES INC.
• THERMO FISHER SCIENTIFIC
• TREVIGEN INC. (BIO-TECHNE)
• その他の3D細胞培養企業
• 3D BIOTEK LLC
• ADVANCED BIOMATRIX INC.
• HORIZON DISCOVERY LTD.
• INSPHERO INC.
• PROMOCELL GMBH
• REPROCELL INC.
• SYNTHECON INC.

List of Tables

• Summary Table : Global Market for Organoids, by Organ Type, Through 2027

Table A : Comparison of Changes in the Segmentation of the Old and New Version of the Report

• Table 1 : Global Market for Organoids, by Organ Type, Through 2027
• Table 2 : Global Market for Intestine Organoids, by Region, Through 2027
• Table 3 : Global Market for Liver Organoids, by Region, Through 2027
• Table 4 : Global Market for Stomach Organoids, by Region, Through 2027
• Table 5 : Global Market for Pancreatic Organoids, by Region, Through 2027
• Table 6 : Global Market for Lung Organoids, by Region, Through 2027
• Table 7 : Global Market for Kidney Organoids, by Region, Through 2027
• Table 8 : Global Market for Other Organoids Segment, by Region, Through 2027
• Table 9 : Global Market for Organoids, by Application, Through 2027
• Table 10 : Global Market for Organoids in Developmental Biology, by Region, Through 2027
• Table 11 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, Through 2027
• Table 12 : Global Market for Organoids in Regenerative Medicine, by Region, Through 2027
• Table 13 : Global Market for Organoids in Pathology of Infectious Disease, by Region, Through 2027
• Table 14 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, Through 2027
• Table 15 : Global Market for Organoids, by Region, Through 2027
• Table 16 : North American Market for Organoids, by Organ Type, Through 2027
• Table 17 : North American Market for Organoids, by Country, Through 2027
• Table 18 : European Market for Organoids, by Organ Type, Through 2027
• Table 19 : European Market for Organoids, by Country, Through 2027
• Table 20 : Asia-Pacific Market for Organoids, by Organ Type, Through 2027
• Table 21 : Asia-Pacific Market for Organoids, by Country, Through 2027
• Table 22 : Rest of the World Market for Organoids, by Organ Type, Through 2027
• Table 23 : Review of Selected Patents and Patent Applications on Organoids, 2008-2021
• Table 24 : Global Number of Transplanted Organs, by Country, 2017
• Table 25 : Global Organoids Vendors, by Ranking, 2021
• Table 26 : Alpha Genesis Inc.: Recent Developments, 2017-2020
• Table 27 : Charles River Laboratories International Inc.: Recent Developments, 2020-2022
• Table 28 : Envigo: Types of Laboratory Animals
• Table 29 : Envigo: Recent Developments, 2021-2022
• Table 30 : GenOway: Recent Developments, 2018-2022
• Table 31 : LabCorp Drug Development: Recent Developments, 2022
• Table 32 : The Jackson Laboratory: Recent Developments, 2021
• Table 33 : Janvier Labs: Segments
• Table 34 : Taconic Biosciences: Segments
• Table 35 : Transgenic Inc.: Segments
• Table 36 : Transgenic Inc.: Company Financials, 2014-2018
• Table 37 : Transposagen Biopharmaceuticals Inc.: Segments
• Table 38 : Organovo: Expenses on R&D, 2016-2020
• Table 39 : Cellesce.: Recent Developments, 2018-2022
• Table 40 : Cincinnati Children's Hospital Medical Center: Recent Developments, 2021
• Table 41 : Crown Bioscience: Recent Developments, 2021-2022
• Table 42 : Corning Inc.: Recent Developments, 2018-2021
• Table 43 : DefiniGEN: Recent Developments, 2020-2021
• Table 44 : Hubrecht Organoid Technology (HUB): Recent Developments, 2017-2021
• Table 45 : Merck KGaA: Products Offered
• Table 46 : Merck KGaA: Recent Developments, 2020-2021
• Table 47 : STEMCELL Technologies Inc.: Recent Developments, 2018-2022
• Table 48 : Thermo Fisher Scientific: Products Offered
• Table 49 : Thermo Fisher Scientific: Recent Developments
• Table 50 : 3D Biotek LLC: Segments
• Table 51 : In Sphero Inc.: Segments
• Table 52 : Reprocell Inc.: Acquisitions

List of Figures

• Summary Figure : Global Market Share for Organoids, by Organ Type, 2021
• Figure 1 : Timeline for Possible Availability of 3D-Printed Organs and Tissues for Humans, 2018-2043
• Figure 2 : Timeline for Possible Availability of Organ-on-Chip Devices for Drug Screening in Human Patients, 2018-2030
• Figure 3 : Global Market Share for Organoids, by Organ Type, 2021
• Figure 4 : Global Market for Intestine Organoids, 2020-2027
• Figure 5 : Global Market for Intestine Organoids, by Region, 2020-2027
• Figure 6 : Global Market for Liver Organoids, 2020-2027
• Figure 7 : Global Market for Liver Organoids, by Region, 2020-2027
• Figure 8 : Global Market for Stomach Organoids, 2020-2027
• Figure 9 : Global Market for Stomach Organoids, by Region, 2020-2027
• Figure 10 : Global Market for Pancreatic Organoids, 2020-2027
• Figure 11 : Global Market for Pancreatic Organoids, by Region, 2020-2027
• Figure 12 : Global Market for Lung Organoids, 2020-2027
• Figure 13 : Global Market for Lung Organoids, by Region, 2020-2027
• Figure 14 : Global Market for Kidney Organoids, 2020-2027
• Figure 15 : Global Market for Kidney Organoids, by Region, 2020-2027
• Figure 16 : Global Market for Other Organoids Segment, 2020-2027
• Figure 17 : Global Market for Other Organoids Segment, by Region, 2020-2027
• Figure 18 : Global Market Share for Organoids, by Application, 2021
• Figure 19 : Global Market for Organoids in Developmental Biology, 2020-2027
• Figure 20 : Global Market for Organoids in Developmental Biology, by Region, 2020-2027
• Figure 21 : Global Market for Organoids in Drug Discovery and Personalized Medicine, 2020-2027
• Figure 22 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, 2020-2027
• Figure 23 : Global Market for Organoids in Regenerative Medicine, 2020-2027
• Figure 24 : Global Market for Organoids in Regenerative Medicine, by Region, 2020-2027
• Figure 25 : Global Market for Organoids in Pathology of Infectious Disease, 2020-2027
• Figure 26 : Global Market for Organoids in Pathology of Infectious Disease, by Region, 2020-2027
• Figure 27 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, 2020-2027
• Figure 28 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, 2020-2027
• Figure 29 : Global Market for Organoids, by Region, 2020-2027
• Figure 30 : Global Market Share for Organoids, by Region, 2021
• Figure 31 : North American Market Share for Organoids, by Organ Type, 2021
• Figure 32 : North American Market Share for Organoids, by Country, 2021
• Figure 33 : U.S. Market for Organoids, 2020-2027
• Figure 34 : Canadian Market for Organoids, 2020-2027
• Figure 35 : European Market Share for Organoids, by Organ Type, 2021
• Figure 36 : European Market Share for Organoids, by Country, 2021
• Figure 37 : German Market for Organoids, 2020-2027
• Figure 38 : French Market for Organoids, 2020-2027
• Figure 39 : U.K. Market for Organoids, 2020-2027
• Figure 40 : Italian Market for Organoids, 2020-2027
• Figure 41 : Spanish Market for Organoids, 2020-2027
• Figure 42 : Rest of the European Market for Organoids, 2020-2027
• Figure 43 : Asia-Pacific Market Share for Organoids, by Organ Type, 2021
• Figure 44 : Asia-Pacific Market Share for Organoids, by Country, 2021
• Figure 45 : Chinese Market for Organoids, 2020-2027
• Figure 46 : Japanese Market for Organoids, 2020-2027
• Figure 47 : Australian Market for Organoids, 2020-2027
• Figure 48 : Indian Market for Organoids, 2020-2027
• Figure 49 : Rest of Asia-Pacific Market for Organoids, 2020-2027
• Figure 50 : Rest of the World Market Share for Organoids, by Organ Type, 2021
• Figure 51 : Global Number of Transplanted Organs, by Country, 2017
• Figure 52 : Charles River Laboratories International Inc.: Net Revenue, 2017-2021
• Figure 53 : Charles River Laboratories International Inc.: Revenue Share, by Business Segment, 2021
• Figure 54 : Charles River Laboratories International Inc.: Revenue Share, by Region, 2021
• Figure 55 : GenOway: Net Revenue, 2019-2021
• Figure 56 : LabCorp Drug Development: Net Revenue, 2017-2021
• Figure 57 : LabCorp Drug Development: Revenue Share, by Business Segment, 2021
• Figure 58 : LabCorp Drug Development: Revenue Share, by Region, 2021
• Figure 59 : The Jackson Laboratory: Net Revenue, 2018-2020
• Figure 60 : The Jackson Laboratory: Revenue Share, by Business Segment, 2020
• Figure 61 : Corning Inc.: Net Revenue, 2019-2021
• Figure 62 : Corning Inc.: Revenue Share, by Business Segment, 2020
• Figure 63 : Corning Inc.: Revenue Share, by Region, 2020
• Figure 64 : Merck KGaA: Net Revenue, 2017-2021
• Figure 65 : Merck KGaA: Revenue Share, by Business Segment, 2020
• Figure 66 : Merck KGaA: Revenue Share, by Region, 2020
• Figure 67 : Thermo Fisher Scientific: Net Revenue, 2017-2021
• Figure 68 : Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020
• Figure 69 : Thermo Fisher Scientific: Revenue Share, by Region, 2020

Highlights:

The global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a compound annual growth rate (CAGR) of 22.2% from 2022 through 2027.

The global market for intestine organoids is estimated to increase from $320.3 million in 2022 to reach $885.2 million by 2027 with a CAGR of 22.5% from 2022 through 2027.

The global market for kidney organoids is estimated to increase from $118.6 million in 2022 to reach $336.0 million by 2027 with a CAGR of 23.2% from 2022 through 2027.

Report Scope:

The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.

Report Includes:

• 26 data tables and 28 additional tables
• An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
• Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
• Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region
• Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc.
• Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds
• Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
• Review of selected patents and patent applications on organoids, and emerging developments in the global market
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Descriptive company profiles of the leading Organoids market players, including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB), and STEMCELL Technologies Inc.

Table of Contents

Chapter 1 Introduction

• Background
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in This Update?
• Information Sources and Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Animal Model Market Technology Background

• Methods of Animal Model and 3D Cell Culture Modification
• Physical and Chemical Mutations
• Targeted Mutations
• Other Technologies
• Laboratory Animal Models
• Market Definition
• Animal Model Lines
• Common Species of Laboratory Animals

Chapter 4 Impact of COVID-19 on the Global Market for Organoids

• Overview
• Impact of COVID-19 on Organoids
• Conclusion

Chapter 5 Market Dynamics

• Market Drivers
• Increasing Emphasis on Developing Alternative Approaches to Animal Testing
• Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth
• Increasing Adoption of the Organoid Technology for Wide Range of Applications
• Market Restraints
• Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells
• Concerns Associated with the Integration of Organoids into Current Workflows
• Market Opportunities
• Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine

Chapter 6 3D Cell Technology Background

• 3D Cell Cultures
• Spheroids
• 2D Cultures vs. 2.5D Cultures vs. 3D Cultures
• Scaffold-Based and Scaffold-Free 3D Cell Cultures
• Scaffold-Free 3D Cell Cultures
• Scaffold-Based 3D Cell Cultures
• Tissue Engineering and Bioprinting
• 3D Bioprinting Technology
• Types of Bioprinting Methods
• Microfluidic Organ-on-Chip Platforms
• Types of Organ-on-Chip Devices

Chapter 7 Market Breakdown by Organ Type

• Global Market for Organoids, by Organ Type
• Intestine
• Market Size and Forecast
• Liver
• Market Size and Forecast
• Stomach
• Market Size and Forecast
• Pancreas
• Market Size and Forecast
• Lung (Pulmonary)
• Market Size and Forecast
• Kidney
• Market Size and Forecast
• Others
• Cardiac Organoids
• Cancer Organoids
• Market Size and Forecast

Chapter 8 Market Breakdown by Application

• Global Market for Organoids, by Application
• Developmental Biology
• Market Size and Forecast
• Drug Discovery and Personalized Medicine
• Market Size and Forecast
• Regenerative Medicine
• Market Size and Forecast
• Pathology of Infectious Disease
• Market Size and Forecast
• Drug Toxicity and Efficacy Testing
• Market Size and Forecast

Chapter 9 Market Breakdown by Region

• Global Market for Organoids, by Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• Australia
• India
• Rest of Asia-Pacific
• Rest of the World
• Market Size and Forecast

Chapter 10 Patent Review/New Developments

Chapter 11 Analysis of Market Opportunities

• Market Opportunities: Animal Models
• Market Opportunities: 3D Cell Culture Segment
• Organs-on-Chip
• Organoids
• Bioprinting
• Advantages and Disadvantages of 3D Cell Cultures and Animal Models
• Animal Models
• 3D Cell Cultures in General
• Organoids
• Organs-on-Chip

Chapter 12 Competitive Landscape

Chapter 13 Profiles of Companies and Important Institutions

• Animal Model Companies
• ALPHA GENESIS INC.
• CHARLES RIVER LABORATORIES INTERNATIONAL INC.
• ENVIGO
• GENOWAY S.A.
• LABCORP DRUG DEVELOPMENT (COVANCE INC.)
• THE JACKSON LABORATORY
• JANVIER LABS
• OAK HILL GENETICS
• PRIMGEN
• TACONIC BIOSCIENCES
• TRANSGENIC INC.
• TRANSPOSAGEN BIOPHARMACEUTICALS INC.
• Bioprinting and Regenerative Medicine Companies
• ALLEVI
• ASPECT BIOSYSTEMS LTD.
• BIOINK SOLUTIONS INC.
• CELLINK INC.
• COLLPLANT HOLDINGS LTD.
• EAST RIVER BIOSOLUTIONS/XYLYX BIO
• EPIBONE
• MATTEK CORP.
• NANO 3D BIOSCIENCES INC.
• ORGANOVO HOLDINGS INC.
• PEPGEL LLC
• REGENHU
• TEVIDO BIODEVICES INC.
• TISSUSE GMBH
• Organ-on-Chip Companies
• AXOSIM
• EMULATE INC.
• KIRKSTALL LTD.
• MICRONIT MICROTECHNOLOGIES
• MIMETAS
• TARA BIOSYSTEMS INC.
• Organoid Companies
• 3DNAMICS INC.
• CELLESCE
• CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
• CROWN BIOSCIENCE
• CORNING INC.
• DEFINIGEN
• HUBRECHT ORGANOID TECHNOLOGY (HUB)
• MERCK KGAA
• R&D SYSTEMS INC.
• STEMCELL TECHNOLOGIES INC.
• THERMO FISHER SCIENTIFIC
• TREVIGEN INC. (BIO-TECHNE)
• Other 3D Cell Culture Companies
• 3D BIOTEK LLC
• ADVANCED BIOMATRIX INC.
• HORIZON DISCOVERY LTD.
• INSPHERO INC.
• PROMOCELL GMBH
• REPROCELL INC.
• SYNTHECON INC.